Targeting of human Tmolt4 leukemic type II IMP dehydrogenase by cyclic imide related derivatives. - Hall IH; Barnes BJ; Ward ES; Wheaton JR; Shaffer KA; Cho SE; Warren AE (Archiv der Pharmazie, 2001)